Report: UK and US plan to reach agreement on zero tariffs for pharmaceuticals.

According to The Times, the British government is on the verge of reaching a major drug agreement with the United States, which will mean zero tariffs on exports of British drugs to America and an increase in the UK National Health Service's drug spending. The agreement, reached after months of lengthy negotiations, comes against the backdrop of fierce criticism and withdrawal of investments in Britain by multinational pharmaceutical companies. Industry sources revealed that, according to the terms of the agreement expected to be announced in the coming days, the British government has agreed to reduce the industry sales rebate rate on NHS drugs and improve the cost-effectiveness assessment criteria for NHS drugs. The current limit of 30,000 per quality-adjusted life year, used to measure the cost of treatment needed for each healthy individual's life, is expected to increase by approximately 25%. It is also reported that the government will commit to increasing the share of drug spending in the NHS budget.